BBNX - Beta Bionics, Inc.
10.61
-0.500 -4.713%
Share volume: 906,856
Last Updated: 03-06-2026
Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies:
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$11.11
-0.50
-0.05%
Fundamental analysis
35%
Profitability
35%
Dept financing
22%
Liquidity
73%
Performance
30%
Performance
5 Days
-15.26%
1 Month
-23.50%
3 Months
-62.52%
6 Months
-54.13%
1 Year
-34.26%
2 Year
-55.10%
Key data
Stock price
$10.61
DAY RANGE
$10.44 - $11.09
52 WEEK RANGE
$8.89 - $32.71
52 WEEK CHANGE
-$29.22
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
05-06-2025
Company detail
CEO: Sean Saint
Region: US
Website: www.betabionics.com
Employees: 294
IPO year: 2025
Issue type:
Market: NASDAQ
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing
Region: US
Website: www.betabionics.com
Employees: 294
IPO year: 2025
Issue type:
Market: NASDAQ
Industry: Medical Equipment/Surgical, Medical, And Dental Instruments And Supplies
Sector: Manufacturing
We are a commercial-stage medical device company engaged in the design, development and commercialization of innovative solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing advanced adaptive closed-loop algorithms to simplify and improve the treatment of their disease. Our principal executive offices are located at 11 Hughes, Irvine, California.
Recent news